FDA Unveils Guidance On Sharing Info On Unapproved Uses
The U.S. Food and Drug Administration on Tuesday unveiled final guidance outlining its recommendations on how companies can share information with insurers about drugs and medical devices that's not included in...To view the full article, register now.
Already a subscriber? Click here to view full article